EURK:NASDAQEureka Acquisition Corp Analysis

EURK is trading at $11.35, just above its 20‑day SMA of 11.24 and 50‑day SMA of 11.19, with the 200‑day SMA at 10.85, indicating a short‑term uptrend that is supported by a bullish MACD (0.042 line above the 0.028 signal) and a high RSI of 73.9, which suggests momentum but also approaching overbought territory. Volume is increasing and the price sits between a support level of 11.16 and resistance around 11.35, while the Fear & Greed Index at 77.3 (Extreme Greed) reflects strong market optimism. However, the company has no operating revenue, negative cash flows, a massive debt load of $1.05 bn, and a negative book value per share of -0.31, resulting in a price‑to‑book ratio of -36.7 and no earnings to justify the price. The recent news of a one‑month extension to the business‑combination deadline (now April 3, 2026) adds timing uncertainty to an already speculative SPAC structure. With a near‑zero beta and 30‑day volatility of about 5.3%, price swings are modest relative to the market, but the lack of fundamentals makes the rally fragile. In this context, the bullish technical picture is outweighed by severe financial weakness and execution risk.